PIEZO1 and Hyperglycemia: Piezo1, via CaMKII-mediated eNOS activation, induces hyperosmolarity-driven endothelial vasodilation during hyperglycemia, disrupts the medullary osmotic gradient, leading to excessive fluid and sodium excretion, and increases GFR in mice.